DGAP-News

Carl Zeiss Meditec AG: Carl Zeiss Meditec AG grows in Ophthalmology and Microsurgery

DGAP-News: Carl Zeiss Meditec AG / Key word(s): 9-month figures
Carl Zeiss Meditec AG: Carl Zeiss Meditec AG grows in Ophthalmology and
Microsurgery

12.08.2016 / 07:00
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Press Release

Carl Zeiss Meditec AG grows in Ophthalmology and Microsurgery

Revenue, EBIT and earnings per share show positive development

JENA, 12 August 2016

In the first nine months of fiscal year 2015/16 medical technology company
Carl Zeiss Meditec AG increased its revenue by 6.7 percent to EUR 798.6
million (adjusted for currency effects: 4.5 percent). All Strategic
Business Units (SBU) and regions contributed to growth in the reporting
period, however, at varying rates. Earnings before interest and taxes
(EBIT) at EUR 110.5 million (prior year: EUR 89.5 million) developed
positively, corresponding to an EBIT margin at 13.8 percent (prior year:
12.0 percent). Earnings per share were EUR 0.83 (prior year EUR 0.64).

Substantial growth was posted by the two strategic business units of
Ophthalmology: The Ophthalmic Systems SBU (OPH) increased revenue after
nine months by 7.5 percent to EUR 304.9 million compared to EUR 283.5
million in the same period of the previous year. Adjusted for currency
effects, revenue increased by 5.0 percent. The Surgical Ophthalmology SBU
(SUR) increased its revenue by 8.6 percent (adjusted for currency effects:
7.1 percent) to EUR 280.8 million (prior year: EUR 258.5 million).

In the Microsurgery SBU, revenue growth was 3.0 percent and mainly due to
favorable exchange rates. Revenue climbed to EUR 212.8 million, compared
with EUR 206.7 million in the same period of the previous year. Based on
constant exchange rates, growth would have been 0.6 percent.

Asia once again growth engine

In the reporting regions, the major part of growth was accounted for by the
APAC region in the first three quarters of the current fiscal year.

In the EMEA region, a slight increase in revenue was reported by 0.2
percent to EUR 262.5 million (prior year: EUR 261.9 million), whereas
Germany and France enjoyed growth. However, the business trend in Middle
East and Africa was declining.

Revenue in the Americas region increased by 0.9 percent to EUR 257.3
million (prior year: EUR 255.2 million). The strength of the US dollar had
a positive effect in this region.
After adjustment for currency effects, a decline by -2.9 percent was
reported compared to the previous year, which was due to continued strong
pressure from competition and difficult economic conditions in parts of